Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Specific Clinical Experience Investigation for Long-term Use of Bydureon

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01940770
First received: September 9, 2013
Last updated: October 27, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: April 2020 (Final data collection date for primary outcome measure)